The metabolism of the cell danger response, healing, and ME/CFS
Dr. Naviaux is Professor of Medicine, Pediatrics, and Pathology at the University of California, San Diego (UCSD). He is the founder and co-director of the Mitochondrial and Metabolic Disease Center, former President of the Mitochondrial Medicine Society (MMS), and a founding associate editor of the journal Mitochondrion. He is an internationally known expert in human genetics, inborn errors of metabolism, metabolomics, and mitochondrial medicine. Dr. Naviaux discovered the genetic basis of Alpers syndrome, the oldest Mendelian form of mitochondrial disease, and developed the first DNA test to diagnose it. He studied biochemistry at Georg-August University in Göttingen, Germany, and received his MD and PhD in Genetics and Virology from the Indiana University School of Medicine. He is currently the director of the first FDA-approved clinical trial to study the safety and test the effects of suramin on behavior and language in children with autism. Dr. Naviaux is a member of the OMF Scientific Advisory Board.